Wolverine Asset Management LLC Clene Inc. Transaction History

Wolverine Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	BUY	$0.95 - $1.62 $171 - $293	181 New	181 $0
Q2 2022 Aug 03, 2022	SELL	$2.1 - $4.12 $487 - $955	-232 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$3.95 - $7.53 $916 - $1,746	232 New	232 $0
Q1 2021 May 13, 2021	SELL	$6.39 - $16.3 $4,619 - $11,784	-723 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$10.75 - $12.97 $7,772 - $9,377	723 New	723 $6,000

7.44M

48.1K

160K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $21M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.